Analysis of the key themes driving private equity deal activity reveals that robotics accounted for 2 medical devices deals announced in Q2 2023, worth a total value of $28m. The $23m investment by Cigna Ventures, Hikma Ventures, Hunt Holdings, LabCorp Venture Fund, Marshall Wace, Maywic Select Investments, Merck Global Health Innovation Fund, Red and Blue Ventures and Safeguard Scientifics in Prognos Health was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, robotics-related deal activity decreased by % in Q2 2023 compared with the previous quarter’s total of . Related deal volume remained flat in Q2 2023 versus the previous quarter.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2023 – Thematic Intelligence, buy the report here.